Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help
Search by PDB author
7DZD
DownloadVisualize
BU of 7dzd by Molmil
Crystal structure of uPA in complex with cleaved camostat
Descriptor: 4-carbamimidamidobenzoic acid, TRIETHYLENE GLYCOL, Urokinase-type plasminogen activator
Authors:Jiang, L.G, Huang, M.D.
Deposit date:2021-01-25
Release date:2021-07-14
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (2 Å)
Cite:Crystal structure of uPA in complex with cleaved camostat
To Be Published
3MWI
DownloadVisualize
BU of 3mwi by Molmil
The complex crystal Structure of Urokianse and 5-nitro-1H-indole-2-amidine
Descriptor: 5-nitro-1H-indole-2-carboximidamide, SULFATE ION, Urokinase-type plasminogen activator
Authors:Jiang, L.G, Yu, H.Y, Yuan, C, Huang, Z.X, Huang, M.D.
Deposit date:2010-05-06
Release date:2011-06-01
Last modified:2023-11-01
Method:X-RAY DIFFRACTION (2.03 Å)
Cite:The complex crystal Structure of Urokianse and 5-nitro-1H-indole-2-amidine
To be Published
3OY6
DownloadVisualize
BU of 3oy6 by Molmil
The crystal structure of uPA complex with peptide inhibitor MH036 at pH4.6
Descriptor: MH036, Urokinase-type plasminogen activator
Authors:Jiang, L.G, Andreasen, P.A, Huang, M.D.
Deposit date:2010-09-22
Release date:2011-08-10
Last modified:2023-11-01
Method:X-RAY DIFFRACTION (2.31 Å)
Cite:The binding mechanism of a peptidic cyclic serine protease inhibitor
J.Mol.Biol., 412, 2011
3OY5
DownloadVisualize
BU of 3oy5 by Molmil
The crystal structure of uPA complex with peptide inhibitor MH027 at pH7.4
Descriptor: MH027, SULFATE ION, Urokinase-type plasminogen activator
Authors:Jiang, L.G, Andreasen, P.A, Huang, M.D.
Deposit date:2010-09-22
Release date:2011-08-10
Last modified:2023-11-01
Method:X-RAY DIFFRACTION (2.31 Å)
Cite:The binding mechanism of a peptidic cyclic serine protease inhibitor
J.Mol.Biol., 412, 2011
3OX7
DownloadVisualize
BU of 3ox7 by Molmil
The crystal structure of uPA complex with peptide inhibitor MH027 at pH4.6
Descriptor: MH027, SULFATE ION, TETRAETHYLENE GLYCOL, ...
Authors:Jiang, L.G, Andreasen, P.A, Huang, M.D.
Deposit date:2010-09-21
Release date:2011-08-10
Last modified:2023-11-01
Method:X-RAY DIFFRACTION (1.58 Å)
Cite:The binding mechanism of a peptidic cyclic serine protease inhibitor
J.Mol.Biol., 412, 2011
5YC6
DownloadVisualize
BU of 5yc6 by Molmil
The crystal structure of uPA in complex with 4-Bromobenzylamirne at pH4.6
Descriptor: 1-(4-BROMOPHENYL)METHANAMINE, SULFATE ION, TRIETHYLENE GLYCOL, ...
Authors:Jiang, L.G, Zhang, X, Huang, M.D.
Deposit date:2017-09-06
Release date:2018-10-03
Last modified:2023-11-22
Method:X-RAY DIFFRACTION (1.18 Å)
Cite:Halogen bonding for the design of inhibitors by targeting the S1 pocket of serine proteases
Rsc Adv, 8, 2018
5YC7
DownloadVisualize
BU of 5yc7 by Molmil
The crystal structure of uPA in complex with 4-Bromobenzylamirne at pH7.4
Descriptor: 1-(4-BROMOPHENYL)METHANAMINE, SULFATE ION, Urokinase-type plasminogen activator
Authors:Jiang, L.G, Zhang, X, Huang, M.D.
Deposit date:2017-09-06
Release date:2018-10-03
Last modified:2023-11-22
Method:X-RAY DIFFRACTION (2 Å)
Cite:Halogen bonding for the design of inhibitors by targeting the S1 pocket of serine proteases
Rsc Adv, 8, 2018
5YUP
DownloadVisualize
BU of 5yup by Molmil
Crystal Structure of the Fab fragment of FVIIa antibody mAb4F5
Descriptor: the heavy chain of the Fab fragment of FVIIa antibody mAb4F5, the light chain of the Fab fragment of FVIIa antibody mAb4F5
Authors:Jiang, L.G, Persson, E, Huang, M.D.
Deposit date:2017-11-22
Release date:2019-06-19
Last modified:2023-11-22
Method:X-RAY DIFFRACTION (1.81 Å)
Cite:Crystal structure, epitope, and functional impact of an antibody against a superactive FVIIa provide insights into allosteric mechanism.
Res Pract Thromb Haemost, 3, 2019
5Z1C
DownloadVisualize
BU of 5z1c by Molmil
The crystal structure of uPA in complex with 4-Iodobenzylamine at pH7.4
Descriptor: 1-(4-iodophenyl)methanamine, Urokinase-type plasminogen activator
Authors:Jiang, L.G, Zhang, X, Luo, Z.P, Huang, M.D.
Deposit date:2017-12-25
Release date:2018-12-26
Last modified:2023-11-22
Method:X-RAY DIFFRACTION (1.45 Å)
Cite:Halogen bonding for the design of inhibitors by targeting the S1 pocket of serine proteases
Rsc Adv, 49, 2018
6JYP
DownloadVisualize
BU of 6jyp by Molmil
Crystal structure of uPA_H99Y in complex with 3-azanyl-5-(azepan-1-yl)-N-[bis(azanyl)methylidene]-6-chloranyl-pyrazine-2-carboxamide
Descriptor: 3-azanyl-5-(azepan-1-yl)-N-[bis(azanyl)methylidene]-6-chloranyl-pyrazine-2-carboxamide, SULFATE ION, Urokinase-type plasminogen activator
Authors:Buckley, B, Jiang, L.G, Huang, M.D, Kelso, M, Ranson, M.
Deposit date:2019-04-27
Release date:2020-05-13
Last modified:2023-11-22
Method:X-RAY DIFFRACTION (2.25 Å)
Cite:uPA-HMA
To Be Published
6JYQ
DownloadVisualize
BU of 6jyq by Molmil
Crystal structure of uPA_H99Y in complex with 3-azanyl-5-(azepan-1-yl)-N-carbamimidoyl-6-(furan-2-yl)pyrazine-2-carboxamide
Descriptor: 3-azanyl-5-(azepan-1-yl)-N-carbamimidoyl-6-(furan-2-yl)pyrazine-2-carboxamide, SULFATE ION, Urokinase-type plasminogen activator
Authors:Buckley, B, Jiang, L.G, Huang, M.D, Kelso, M, Ranson, M.
Deposit date:2019-04-27
Release date:2020-05-13
Last modified:2023-11-22
Method:X-RAY DIFFRACTION (1.75 Å)
Cite:H99Y-6F-HMA-pH7
To Be Published
6L05
DownloadVisualize
BU of 6l05 by Molmil
Crystal structure of uPA_H99Y in complex with 50F
Descriptor: 3-azanyl-5-(azepan-1-yl)-6-(1-benzofuran-2-yl)-Ncarbamimidoyl-pyrazine-2-carboxamide, Urokinase-type plasminogen activator
Authors:Buckley, B, Jiang, L.G, Huang, M.D, Kelso, M, Ranson, M.
Deposit date:2019-09-26
Release date:2020-09-30
Last modified:2023-11-22
Method:X-RAY DIFFRACTION (2.49 Å)
Cite:Crystal structure of uPA_H99Y in complex with 50F
To Be Published
6L04
DownloadVisualize
BU of 6l04 by Molmil
Crystal structure of uPA_H99Y in complex with 31F
Descriptor: 3-azanyl-5-(azepan-1-yl)-N-carbamimidoyl-6-(2,4-dimethoxypyrimidin-5-yl)pyrazine-2-carboxamide, Urokinase-type plasminogen activator
Authors:Buckley, B, Jiang, L.G, Huang, M.D, Kelso, M, Ranson, M.
Deposit date:2019-09-26
Release date:2020-09-30
Last modified:2023-11-22
Method:X-RAY DIFFRACTION (2.21 Å)
Cite:Crystal structure of uPA_H99Y in complex with 31F
To Be Published
3G7N
DownloadVisualize
BU of 3g7n by Molmil
Crystal Structure of a Triacylglycerol Lipase from Penicillium Expansum at 1.3
Descriptor: DI(HYDROXYETHYL)ETHER, Lipase, PENTAETHYLENE GLYCOL, ...
Authors:Bian, C.B, Yuan, C, Chen, L.Q, Edward, J.M, Lin, L, Jiang, L.G, Huang, Z.X, Huang, M.D.
Deposit date:2009-02-10
Release date:2010-02-23
Last modified:2017-11-01
Method:X-RAY DIFFRACTION (1.3 Å)
Cite:Crystal structure of a triacylglycerol lipase from Penicillium expansum at 1.3 A determined by sulfur SAD
Proteins, 78, 2010
7WOK
DownloadVisualize
BU of 7wok by Molmil
Crystal structure of HSA soaked with cisplatin for one week
Descriptor: Albumin, Cisplatin, PHOSPHATE ION
Authors:Chen, S.L, Yuan, C, Jiang, L.G, Luo, Z.P, Huang, M.D.
Deposit date:2022-01-21
Release date:2022-07-20
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (2.9 Å)
Cite:Crystallographic analysis of interaction between cisplatin and human serum albumin: Effect of fatty acid.
Int.J.Biol.Macromol., 216, 2022
7WOJ
DownloadVisualize
BU of 7woj by Molmil
Crystal structure of HSA-Myr complex soaked with cisplatin for one week
Descriptor: Albumin, Cisplatin, MYRISTIC ACID
Authors:Chen, S.L, Yuan, C, Jiang, L.G, Luo, Z.P, Huang, M.D.
Deposit date:2022-01-21
Release date:2022-07-20
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (2.89 Å)
Cite:Crystallographic analysis of interaction between cisplatin and human serum albumin: Effect of fatty acid.
Int.J.Biol.Macromol., 216, 2022
6AG7
DownloadVisualize
BU of 6ag7 by Molmil
The crystal structure of uPA in complex with HMA-55F
Descriptor: 3,5-diamino-N-carbamimidoyl-6-(1-methyl-1H-pyrazol-4-yl)pyrazine-2-carboxamide, Urokinase-type plasminogen activator
Authors:Buckley, B, Jiang, L.G, Majed, H, Huang, M.D, Kelso, M, Ranson, M.
Deposit date:2018-08-09
Release date:2019-08-14
Last modified:2023-11-22
Method:X-RAY DIFFRACTION (1.9 Å)
Cite:uPA-HMA
To Be Published
6AG3
DownloadVisualize
BU of 6ag3 by Molmil
Crystal structure of uPA in complex with 3,5-bis(azanyl)-N-carbamimidoyl-6-(2,4-dimethoxypyrimidin-5-yl)pyrazine-2-carboxamide
Descriptor: 3,5-bis(azanyl)-N-carbamimidoyl-6-(2,4-dimethoxypyrimidin-5-yl)pyrazine-2-carboxamide, Urokinase-type plasminogen activator
Authors:Buckley, B, Jiang, L.G, Majed, H, Huang, M.D, Kelso, M, Ranson, M.
Deposit date:2018-08-09
Release date:2019-09-18
Last modified:2023-11-22
Method:X-RAY DIFFRACTION (2.48 Å)
Cite:uPA-HMA
To Be Published
6AG9
DownloadVisualize
BU of 6ag9 by Molmil
Crystal structure of uPA in complex with 3,5-bis(azanyl)-6-(1-benzofuran-2-yl)-N-carbamimidoyl-pyrazine-2- carboxamide
Descriptor: 3,5-bis(azanyl)-6-(1-benzofuran-2-yl)-N-carbamimidoyl-pyrazine-2-carboxamide, SULFATE ION, Urokinase-type plasminogen activator
Authors:Buckley, B, Jiang, L.G, Majed, H, Huang, M.D, Kelso, M, Ranson, M.
Deposit date:2018-08-09
Release date:2019-09-18
Last modified:2023-11-22
Method:X-RAY DIFFRACTION (1.63 Å)
Cite:uPA-HMA
To Be Published
6AG2
DownloadVisualize
BU of 6ag2 by Molmil
uPA-HMA
Descriptor: 3,5-bis(azanyl)-N-carbamimidoyl-6-(2-methoxypyrimidin-5-yl)pyrazine-2-carboxamide, SULFATE ION, Urokinase-type plasminogen activator
Authors:Buckley, B, Jiang, L.G, Huang, M.D, Kelso, M, Ranson, M.
Deposit date:2018-08-09
Release date:2019-09-18
Method:X-RAY DIFFRACTION (1.77 Å)
Cite:uPA-HMA
To Be Published
7VM5
DownloadVisualize
BU of 7vm5 by Molmil
Crystal structure of uPA in complex with 4-guanidinobenzoic acid
Descriptor: 4-carbamimidamidobenzoic acid, TRIETHYLENE GLYCOL, Urokinase-type plasminogen activator
Authors:Jiang, L.G, Huang, M.D.
Deposit date:2021-10-07
Release date:2022-10-12
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (1.97 Å)
Cite:Structural study of the uPA-nafamostat complex reveals a covalent inhibitory mechanism of nafamostat.
Biophys.J., 121, 2022
7VM4
DownloadVisualize
BU of 7vm4 by Molmil
Crystal structure of uPA in complex with nafamostat
Descriptor: 4-carbamimidamidobenzoic acid, TRIETHYLENE GLYCOL, Urokinase-type plasminogen activator
Authors:Jiang, L.G, Huang, M.D.
Deposit date:2021-10-07
Release date:2022-10-12
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (2.01 Å)
Cite:Structural study of the uPA-nafamostat complex reveals a covalent inhibitory mechanism of nafamostat.
Biophys.J., 121, 2022
7VM6
DownloadVisualize
BU of 7vm6 by Molmil
Crystal structure of uPA in complex with 6-amidino-2-naphthol
Descriptor: 6-oxidanylnaphthalene-2-carboximidamide, SULFATE ION, TRIETHYLENE GLYCOL, ...
Authors:Jiang, L.G, Huang, M.D.
Deposit date:2021-10-07
Release date:2022-10-12
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (1.79 Å)
Cite:Structural study of the uPA-nafamostat complex reveals a covalent inhibitory mechanism of nafamostat.
Biophys.J., 121, 2022
7VM7
DownloadVisualize
BU of 7vm7 by Molmil
Crystal structure of inactive uPA in complex with nafamostat
Descriptor: (6-carbamimidoylnaphthalen-2-yl) 4-carbamimidamidobenzoate, Urokinase-type plasminogen activator chain B
Authors:Jiang, L.G, Huang, M.D.
Deposit date:2021-10-07
Release date:2022-11-23
Last modified:2023-11-29
Method:X-RAY DIFFRACTION (1.87 Å)
Cite:Structural study of the uPA-nafamostat complex reveals a covalent inhibitory mechanism of nafamostat.
Biophys.J., 121, 2022
5ZC5
DownloadVisualize
BU of 5zc5 by Molmil
uPA-NU-09F
Descriptor: 3-azanyl-5-(azepan-1-yl)-N-carbamimidoyl-6-(4-fluoranyl-1-benzofuran-2-yl)pyrazine-2-carboxamide, Urokinase-type plasminogen activator chain B
Authors:Jiang, L.G, Buckley, B.J, Huang, M.D, Kelso, M.J, Ranson, M.
Deposit date:2018-02-15
Release date:2018-12-19
Last modified:2023-11-22
Method:X-RAY DIFFRACTION (1.9 Å)
Cite:6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer.
J. Med. Chem., 61, 2018

 

12>

217705

PDB entries from 2024-03-27

PDB statisticsPDBj update infoContact PDBjnumon